Abstract
The activity of phosphodiesterase (PDE) of rat cerebral cortex following the administration in vitro and in vivo of various concentrations of neuroleptic phenothiazine drugs and tricyclic antidepressive drugs has been investigated. It has been shown that PDE activity is inhibited by phenothiazine neuroleptic drugs (fluphenazine > trifluperazine > thioproperazine > chlorpromazine = thioridazine). Tricyclic antidepressants nortriptyline, chlorimipramine, protiptyline, imipramine and desipramine at a concentration of 10−3 M caused 60–80% inhibition of PDE activity. It has also been found that the investigated phenothiazine compounds inhibit the high affinity PDE activity more than the PDE activity of low affinity to the substrate.
The results obtained suggest that the mechanism of the neuroleptic action of phenothiazine drugs is partially connected with their influence on cyclic 3′,5′-AMP metabolism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brooker, G., Thomas, L. J., Appleman, M. M.: The assay of adenosine 3′,5′-cyclic monophosphate and guanosine 3′,5′-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement. Biochemistry 7, 4177–4181 (1968)
Butcher, R. W., Sutherland, E. W.: Adenosine 3′,5′-phosphate in biological materials: I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine. J. biol. Chem. 237, 1244–1250 (1962)
Chasin, M., Rivkin, I., Mamrak, F., Samanieg, S. G., Hess, S. M.: α- and Β-adrenergic receptors as mediators of accumulation of cyclic adenosine 3′,5′-monophosphate in specific areas of guinea pig brain. J. biol. Chem. 246, 3037–3041 (1971)
Cheung, W. Y.: Properties of cyclic 3′,5′-nucleotide phosphodiesterase from rat brain. Biochemistry 6, 1079–1087 (1967)
Greengard, P., Kuo, J.: On the mechanisms of action of cyclic AMP. Role of cyclic AMP in cell function. In: Advances in Biochemical Psychopharmacology, P. Greengard and E. Costa, Eds., vol. 3, pp. 287–306. New York: Raven Press 1970
Honda, F., Imamura, H.: Inhibition of cyclic 3′,5′-nucleotide phosphodiesterase by phenotiazine and reserpine derivatives. Biochim. biophys. Acta (Amst.) 161, 267–269 (1968)
Huang, M., Daly, J. W.: Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 1. Structure-activity relationships of agonists and antagonists of biogenic amines and of tricyclic tranquilizers and antidepressants. J. med. Chem. 15, 458–461 (1972)
Hynie, S., Krishna, G., Brodie, B. B.: Theophylline as a tool in studies of the role of cyclic adenosine 3′,5′-monophosphate in hormone induced lipolysis. J. Pharmacol. exp. Ther. 153, 90–96 (1966)
Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data. Part I. Neuroleptic activity spectra for rats. Arzneimittel-Forsch. 15, 104–117 (1965)
Klotz, U., Berndt, S., Stock, K.: Characterization of multiple cyclic nucleotide phosphodiesterase activities of rat adipose tissue. Life Sci. 11, part II, 7–17 (1972)
Kodama, T., Matsukado, Y., Suzuki, T., Tanaka, S., Shimizu, H.: Stimulated formation of adenosine 3′5′-monophosphate by desipramine in brain slices. Biochim. biophys. Acta (Amst.) 252, 165–170 (1971)
Lineweaver, H., Burk, D.: The determination of enzyme dissociation constants. J. Amer. chem. Soc. 56, 658–666 (1934)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenolreagent. J. biol. Chem. 193, 265–275 (1951)
Palmer, G. C., Robison, G. A., Manian, A. A., Sulser, F.: Modification by psychotropic drugs of the cyclic AMP response to norepinephrine in the rat brain in vitro. Psychopharmacologia (Berl.) 23, 201–211 (1972)
Pichard, A. L., Hanoune, J., Kaplan, J. C.: Human brain and platelet cyclic adenosine 3′,5′-monophosphate phosphodiesterases: Different response to drugs. Biochim. biophys. Acta (Amst.) 279, 217–220 (1972)
Pöch, G.: Assay of phosphodiesterase with radioactively labeled cyclic 3′,5′-AMP as substrate. Naunyn-Schmiedebergs Arch. Pharmak. 268, 272–299 (1971)
Ramsden, E. N.: Cyclic AMP in depression and mania. Lancet 1970 II, 108
Roberts, E., Simonsen, D. G.: Some properties of cyclic 3′,5′-nucleotide phosphodiesterase of mouse brain: effects of imidazole-4-acetic acid, chlorpromazine, cyclic 3′,5′-GMP, and other substances. Brain Res. 24, 91–111 (1970)
Schwabe, U., Brendt, S., Ebert, R.: Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 62–74 (1972)
Sutherland, E. W., Robison, G. A.: The role of cyclic 3′,5′-AMP in responses to catecholamines and other hormones. Pharmacol. Rev. 18, 145–161 (1966)
Sutherland, E. W., Robison, G. A., Butcher, R. W.: Some aspects of the biological role or adenosine 3′,5′-monophosphate (cyclic AMP). Circulation 37, 279–306 (1968)
Thomson, W. J., Appleman, M. M.: Separation and characterisation of multiple forms of 3′,5′-cyclic AMP phosphodiesterase. Fed. Proc. 29, 602 (1970)
Thompson, W. J., Appleman, M. M.: Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10, 311–316 (1971a)
Thompson, W. J., Appleman, M. M.: Characterization of cyclic nucleotide phosphodiesterases of rat tissues. J. biol. Chem. 246, 3145–3150 (1971b)
Uzunov, P., Weiss, B.: Effects of phenothiazine tranquilizers on the cyclic 3′,5′-adenosine monophosphate system of rat brain. Neuropharmacology 10, 699–708 (1971)
Uzunov, P., Weiss, B.: Advances cyclic nucleotides research, Vol. 1, pp. 435–453, New York: Raven Press 1972
Vernikos-Danellis, J., Harries, C. G.: The effect in vitro and in vivo of coffeine, theophilline and hydrocortisone on the phosphodiesterase activity of the pituitary, median eminence, heart and cerebral cortex of the rat. Proc. Soc. exp. Biol. (N. Y.) 128, 1016–1021 (1968)
Weiss, B., Costa, E.: Regional and subcellular distribution of adenyl cyclase and 3′,5′-cyclic nucleotide phosphodiesterase in brain and pineal gland. Biochem. Pharmacol. 17, 2107–2116 (1968)
Author information
Authors and Affiliations
Additional information
Supported by Polish Academy of Sciences, 09.4.1.5.
Rights and permissions
About this article
Cite this article
Janiec, W., Korczak-Dziuba, K. & Herman, Z.S. Effect of phenothiazine neuroleptic drugs and tricyclic antidepressants on phosphodiesterase activity in rat cerebral cortex. Psychopharmacologia 37, 351–358 (1974). https://doi.org/10.1007/BF00428921
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428921